Skip to main content

Department of Cell and Developmental Biology

Genetic and Phenotypic Diversification of Heterogeneous Tumor Populations.

AUTHORS

Elion DL , Cook RS , . Trends in molecular medicine. 2018 8 ; 24(8). 655-656

ABSTRACT

Chemotherapy is the most commonly prescribed treatment for patients with aggressive and lethal triple negative breast cancers (TNBCs), which often develop chemoresistance. A recent study combined single nucleus sequencing, single cell RNA sequencing, and evolutionary biology to understand how tumor cells use genetic and phenotypic diversity to evade the selective pressures of neoadjuvant chemotherapy.

Tags:

VIEW MORE EVENTS >